These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 21400552

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Bilirubin response to corticosteroids in severe alcoholic hepatitis.
    Morris JM, Forrest EH.
    Eur J Gastroenterol Hepatol; 2005 Jul; 17(7):759-62. PubMed ID: 15947554
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Histological activity score on baseline liver biopsy can predict non-response to steroids in patients with severe alcoholic hepatitis.
    Shasthry SM, Rastogi A, Bihari C, Vijayaraghavan R, Arora V, Sharma MK, Sarin SK.
    Virchows Arch; 2018 Apr; 472(4):667-675. PubMed ID: 29516163
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Interleukin-2 receptor antibody (basiliximab) for immunosuppressive induction therapy after liver transplantation: a protocol with early elimination of steroids and reduction of tacrolimus dosage.
    Liu CL, Fan ST, Lo CM, Chan SC, Ng IO, Lai CL, Wong J.
    Liver Transpl; 2004 Jun; 10(6):728-33. PubMed ID: 15162466
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Combination of steroids with infliximab or placebo in severe alcoholic hepatitis: a randomized controlled pilot study.
    Spahr L, Rubbia-Brandt L, Frossard JL, Giostra E, Rougemont AL, Pugin J, Fischer M, Egger H, Hadengue A.
    J Hepatol; 2002 Oct; 37(4):448-55. PubMed ID: 12217597
    [Abstract] [Full Text] [Related]

  • 15. Basiliximab (Simulect) for the treatment of steroid-resistant rejection in pediatric liver transpland recipients: a preliminary experience.
    Aw MM, Taylor RM, Verma A, Parke A, Baker AJ, Hadzic D, Muiesan P, Rela M, Heaton ND, Mieli-Vergani G, Dhawan A.
    Transplantation; 2003 Mar 27; 75(6):796-9. PubMed ID: 12660504
    [Abstract] [Full Text] [Related]

  • 16. Prednisolone plus S-adenosil-L-methionine in severe alcoholic hepatitis.
    Tkachenko P, Maevskaya M, Pavlov A, Komkova I, Pavlov C, Ivashkin V.
    Hepatol Int; 2016 Nov 27; 10(6):983-987. PubMed ID: 27337960
    [Abstract] [Full Text] [Related]

  • 17. Early switch to pentoxifylline in patients with severe alcoholic hepatitis is inefficient in non-responders to corticosteroids.
    Louvet A, Diaz E, Dharancy S, Coevoet H, Texier F, Thévenot T, Deltenre P, Canva V, Plane C, Mathurin P.
    J Hepatol; 2008 Mar 27; 48(3):465-70. PubMed ID: 18164508
    [Abstract] [Full Text] [Related]

  • 18. Anti-interleukin 2 receptor antibodies and mycophenolate mofetil for treatment of steroid-resistant rejection in adult liver transplantation.
    Orr DW, Portmann BC, Knisely AS, Stoll S, Rela M, Muiesan P, Bowles MJ, Heaton ND, O'Grady JG, Heneghan MA.
    Transplant Proc; 2005 Dec 27; 37(10):4373-9. PubMed ID: 16387124
    [Abstract] [Full Text] [Related]

  • 19. [Basiliximab in the treatment of acute steroid-resistant rejection after liver transplantation].
    Alvarez Castro AM, Seijo Ríos S, Molina Pérez E, Castroagudín JF, Varo Pérez E.
    Gastroenterol Hepatol; 2012 Nov 27; 35(9):649-51. PubMed ID: 22749511
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.